INHIBITORS OF CGAS ACTIVITY AS THERAPEUTIC AGENTS

This disclosure relates to compounds, pharmaceutical compositions comprising them, and methods of using the compounds and compositions for treating or preventing inappropriate activation of a type I interferon (IFN) response in a subject in need thereof.

Saved in:
Bibliographic Details
Main Authors BOXER, Matthew, MALONEY, David, KUMAR, Meera, LOWERY, Robert, G
Format Patent
LanguageEnglish
French
German
Published 18.06.2025
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:This disclosure relates to compounds, pharmaceutical compositions comprising them, and methods of using the compounds and compositions for treating or preventing inappropriate activation of a type I interferon (IFN) response in a subject in need thereof.
Bibliography:Application Number: EP20230853244